Condition
Upper Tract Urothelial Cancer
Total Trials
5
Recruiting
5
Active
5
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 4 (1)
Trial Status
Recruiting5
Clinical Trials (5)
Showing 5 of 5 trials
NCT06822010Phase 2Recruiting
SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
NCT06805630Not ApplicableRecruitingPrimary
Urine Methylation Markers in UTUC
NCT06987552Not ApplicableRecruitingPrimary
Single-Port RAS Using Da Vinci SP Surgical System for UTUC Patients
NCT06820255Phase 4Recruiting
DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.
NCT05438537RecruitingPrimary
A Comprehensive Prospective Assessment of the Physical and Biological Effects of Upper Tract Urothelial Cancer (UTUC)
Showing all 5 trials